Opinion

Beating the bloat: The role of nutrition in managing IBS


Rachael Bradford


27/06/2018 1:32:27 PM

Dietitian Rachael Bradford examines how diet and nutrition can effect symptoms related to irritable bowel syndrome.

News teaser
Irritable bowel syndrome affects around one in five Australians.

Happy and healthy bowels are the pillars for the body. They are also the cornerstone of vitality, health and wellbeing.
 
When the gut is working well, people feel vibrant and full of energy. However, a chink in its armour means the body will soon exhibit unpleasant bowel symptoms.
 
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects around one in five Australians. IBS has myriad symptoms, including bloating, excess gas production, diarrhoea and/or constipation, abdominal discomfort or pain.
 
The pathophysiology of IBS is multi-factorial and bouts of gut infection or illness, emotional stress, heightened visceral sensitivity, microbiota balance and dietary factors may all be contributing factors. Visceral hypersensitivity is a key difference in patients with IBS, which may explain the variance of symptomology in individuals, despite the similar colonic gas production from foods present in all individuals.
 
Mounting evidence and research trials in recent years are showing that a low FODMAP diet is the most efficacious dietary intervention for the management of IBS. A low-FODMAP diet leads to a clinical response in 50–80% of patients with IBS, and most notable improvements include reduced bloating, flatulence and diarrhoea.   
 
What are FODMAPs?
FODMAP is an acronym for a number of short-chain carbohydrates:

  • Fermentable
  • Oligosaccharides
  • Disaccharides
  • Monosaccharides (And)
  • Polyols.
Foods that are high in FODMAPs that may be problematic for people with IBS include milk and milk products (lactose), wheat and wheat products (fructans), certain fruits and vegetables (fructans, oligosaccharides, fructose, polyols), legumes and certain nuts (oligosaccharides), some beverages (fructose) and artificially sweetened diet products (polyols).
 
An effect of FODMAPs for people with IBS is the increase in liquidity of the luminal contents of the small intestine. This increased volume, combined with visceral hypersensitivity and subsequent luminal distension, will cause abdominal pain and bloating and, quite likely, looser stools.
 
FODMAPs are poorly absorbed in the small intestine and travel to the colon, where rapid fermentation of the short-chain carbohydrates by bacteria produces methane and hydrogen. This excess gas production is associated with increased flatulence and bloating. It is also thought that foods high in FODMAPs increase gut motility, contributing to looser stools and faecal urgency.
 
Implementing a low-FODMAP diet
The low-FODMAP diet is composed of three separate phases: elimination (2–4 weeks), reintroduction (6–8 weeks) and maintenance. It is best implemented under the guidance of an experienced accredited practising dietitian.
 
Some negative long-term effects of a low FODMAP diet can be a change in the diversity of the gut microbiome. This is due to the reduction of available prebiotic fructans in the intestinal tract that are the very fuel source needed by the valuable probiotics.
 
It is therefore crucial that patients with IBS follow through all three phases, to ensure that only problematic foods are eliminated – and a tolerance threshold of the problematic foods is established. This will ensure that a variety of tolerated short-chain carbohydrates or prebiotic foods are included back into the individual’s diet to build a greater diversity of their gut microbiome. 
 
Probiotics are increasingly being recommended as an adjunct therapy in the treatment of IBS to improve the diversity of an individual’s gut microbiome. A 2014 meta-analysis highlighted that strain-specific probiotics showed an improvement in global IBS symptoms.
 
There is not enough research at this time on the use of fermented foods (eg kefir, kombucha, kimchi, sauerkraut, live yoghurts and natto) in the management of IBS, but this area certainly deserves some merit with clinical observations.
 
The future may indeed lie in a more personalised and targeted FODMAP and gut microbiota therapy for people experiencing IBS.



bloating FODMAPs IBS irritable bowel syndrome





Comments



 Security code